Skip to main content

Drug Monitoring Webinar: Presumptive vs Definitive Drug Testing: What Are We Missing?

Registration information

12:00 PM ET/9:00 AM PT

Sep 21, 2021

The objectives of this webinar include:

  • Learn why, now more than ever, drug testing needs to be incorporated into the standard of clinical care when prescribing controlled substances and assessing patients for medication adherence or drug misuse 
  • Gain a deeper understanding of the differences between presumptive and definitive drug testing
  • Hear results from a recent Quest Diagnostics study using national data, which demonstrate some of the risks of relying solely on point-of-care presumptive testing as a drug monitoring solution


Jack Kain, PharmD
Director, Medical Science Liaison, Quest Diagnostics

Les Edinboro, PhD
Executive Science Director, Toxicology, Quest Diagnostics

Moderated by:

Jeff Gudin, MD
Senior Medical Advisor, Drug Monitoring and Toxicology, Quest Diagnostics


ONE contact hour toward ASCLS P.A.C.E.® credit will be available to participating laboratory professionals who attend the webinar and complete the post evaluation. PACE Credits. Expires 3/21/22